China News
-
WuXi Biologics commences construction of center for Innovative Biologics
China | News | 0 Comment | 17 May, 2019
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that ...Read more
-
CPHI reports first quarter 2019 financial results
China | News | 0 Comment | 15 May, 2019
China Pharma Holdings, an NYSE American-listed corporation with a fully-integrated speciality pharmaceuticals subsidiary based in China has announced financial results for th...Read more
-
China | News | 0 Comment | 15 May, 2019
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has completed a prospective multi-centre clinical trial for the world's fi...Read more
-
Covestro to introduce future drug delivery concept in Asia
China | News | 0 Comment | 15 May, 2019
Covestro is attending the China International Medical Equipment Fair (CMEF) spring show - the leading event in China's medical equipment industry. At the event, Covestro will debu...Read more
-
TRIGR Therapeutics forms Global Clinical & Scientific Advisory Board
China | News | 0 Comment | 13 May, 2019
TRIGR Therapeutics, Inc. ("TRIGR"), a clinical stage biotechnology company focused on the development of multi-targeted and immunomodulatory bispecific antibodies, announced the formation o...Read more
-
MGI raises $200 M in first round of financing
China | News | 0 Comment | 14 May, 2019
MGI, a subsidiary of BGI Group, has disclosed that its first round of fundraising exceeded US$200 million, the largest amount of capital raised in the genetic field in China&...Read more
-
Masimo and Mindray announce expanded partnership
China | News | 0 Comment | 13 May, 2019
Masimo and Shenzhen Mindray Bio-Medical Electronics Co., Ltd have entered into a new purchase and license agreement. The new partnership, under Mindray, will offer Masimo SET® ...Read more
-
TAKE2 licenses technology for Nasopharyngeal Cancer early detection
China | News | 0 Comment | 13 May, 2019
TAKE2 HEALTH LTD., a healthcare technology company based in Hong Kong, China, has entered into a definitive license agreement with GRAIL, Inc., for the exclusive worldwide rights to an inte...Read more
-
ABG leads Pulmonx's $65 million financing
China | News | 0 Comment | 10 May, 2019
Ally Bridge Group ("ABG"), a leading global life science investment group, announced that it led an over-subscribed $65 million financing of Pulmonx Corporation, a global leader i...Read more
-
CloudMinds partners with Retail Pharmacy to implement AI
China | News | 0 Comment | 09 May, 2019
Artificial intelligence (AI) is pioneering a new wave of innovation in the medical industry prompting large healthcare providers to quickly implement AI to adapt to this technological revol...Read more
-
Sandoz receives regulatory approval from NMPA for Rosuvastatin
China | News | 0 Comment | 09 May, 2019
Sandoz has announced that it has received regulatory approval from China's National Medical Products Administration (NMPA) for its generic Rosuvastatin, under the NMPA's Quality Consistency...Read more
-
Research Point Global and WuXi CDS to rebrand as WuXi Clinical
China | News | 0 Comment | 10 May, 2019
The mid-sized CRO market has seen a number of significant changes, and now the recently merged Research Point Global (RPG) and WuXi Clinical Development Services (CDS) are to rebrand as&nbs...Read more
-
Henlius biosimilar HLX02 gets NDA acceptance from NMPA
China | News | 0 Comment | 08 May, 2019
Shanghai Henlius Biotech, Inc., subsidiary of Shanghai Fosun Pharmaceutical Group Co. has recently received a New Drug Application (NDA) acceptance from the National Medical Products Admini...Read more
-
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints
China | News | 0 Comment | 08 May, 2019
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse chimeric anti-cell surface protein (anti-CD20) monoclonal antibody b...Read more
-
Alembic set to sell its drugs into Chinese market
China | News | 0 Comment | 08 May, 2019
Alembic has entered into a Joint Venture Agreement ('JVA') with SPH SINE Pharmaceutical Laboratories Co Ltd, China ('SPH Sine') & Adia (Shanghai) Pharma Co Ltd, China ('Adia') to promot...Read more
-
GeneQuantum completes RMB 100M financing
China | News | 0 Comment | 08 May, 2019
China based GeneQuantum Healthcare announced that it has closed nearly RMB 100 million Pre-B round of financing. This financing was led by Huagai Capital, joined by Hofon Cap...Read more
-
Evolve BioSystems launches Evivo in Hong Kong, Singapore
China | News | 0 Comment | 07 May, 2019
Evolve BioSystems, makers of Evivo® baby probiotic, announced that its flagship consumer product Evivo is available in Hong Kong and Singapore. The introductio...Read more
-
WuXi AppTec to enhance biometrics services for clinical development
China | News | 0 Comment | 07 May, 2019
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, has announced that it has acquired Pharmapace, Inc., a US-based clini...Read more
